Answers are grounded in this paper and cite their sources.
Douglas Richman (University of California at San Diego, USA) captures the current excitement in the field of HIV therapeutics. New drugs, new treatment regimens, and new insights into the relation of disease progression to the quantity of viral RNA in patients' plasma have led to an unprecedented sense of optimism among researchers.
No takes yet. Share an insight, caveat, or question.
Douglas D. Richman (1996) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: